Stockreport

Pressure BioSciences and RedShiftBio Demonstrate Potential of Combining Proprietary Technologies to Enable New Tool for Development and Production of Biotherapeutics

PRESSURE BIOSCIENCES  (PBIO) 
US:NASDAQ Investor Relations: ir.pressurebiosciences.com
PDF SOUTH EASTON, Massachusetts, April 16, 2020 /PRNewswire/ -- Pressure BioSciences, Inc. (OTCQB: PBIO) ("PBI" or the "Company"), a leader in the development and sale of br [Read more]